![](/img/cover-not-exists.png)
Cost-effectiveness model of using zoledronic acid once a year versus current treatment strategies in postmenopausal osteoporosis
Patrice Fardellone, Bernard Cortet, Erick Legrand, Xavier Bresse, Ségolène Bisot-Locard, Anne-Marie Vigneron, Ariel BeresniakVolume:
77
Year:
2010
Language:
english
Pages:
5
DOI:
10.1016/j.jbspin.2009.04.009
File:
PDF, 232 KB
english, 2010